Skip to main content
  • ‘Significant’ Changes in Clinical Characteristics and Outcomes for STEMI Patients with COVID-19 in Early Pandemic: UK Observational Data

    But the difference disappeared in all but unvaccinated STEMI patients with COVID-19 in recent waves

    The clinical characteristics, thrombus burden and outcomes of ST-segment elevation myocardial infarction (STEMI) in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection varied across three waves of the pandemic; however, contemporary outcomes in patients with and without SARS-CoV-2 infection are similar except among unvaccinated COVID-19 patients, report new observational data from the U.K.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details